THE REGENTS OF THE UNIVERSITY OF COLORADO; A BODYCORPORATE
发明人:
申请号:
EP09175439.0
公开号:
EP2145629B1
申请日:
1998.07.15
申请国别(地区):
EP
年份:
2012
代理人:
摘要:
The use of a botulinum toxin, in particular toxin type A, in the preparation of a pharmaceutical composition for treating urinary incontinence. The botulinum toxin may be formulated in a pharmaceutically acceptable formulation for example as a liquid, a powder, a cream, an emulsion, a pill, a troche, a suppository, a suspension, or a solution, and administered into the urinary tract of a human male or a human female.